Purple Biotech appoints Isaac Israel interim CEO as Gil Efron steps down

Purple Biotech appointed director Isaac Israel as interim CEO effective Oct. 5, 2026, pending selection of a permanent chief executive. Outgoing CEO Gil Efron will shift to executive director, head of corporate development.